• No results found

Beta-2 agonist.

Impact of extrafine formulations of inhaled corticosteroids/long-acting beta-2 agonist combinations on patient-related outcomes in asthma and COPD

Impact of extrafine formulations of inhaled corticosteroids/long-acting beta-2 agonist combinations on patient-related outcomes in asthma and COPD

... Abstract: Asthma and chronic obstructive pulmonary disease (COPD) are among the most common chronic diseases worldwide, characterized by a condition of variable degree of airway obstruction and chronic airway ...

10

Inhaled beta 2 agonist salbutamol and acute lung injury: an association with improvement in acute lung injury

Inhaled beta 2 agonist salbutamol and acute lung injury: an association with improvement in acute lung injury

... β 2 ago- nist, aerosolized metaproterenol (5 mg), not only decreases high airway resistance and improves oxygenation, but also increases static compliance in human ...β 2 agonists in ALI because of a ...

7

Risk of pneumonia with inhaled corticosteroid/long-acting β2 agonist therapy in chronic obstructive pulmonary disease: a cluster analysis

Risk of pneumonia with inhaled corticosteroid/long-acting β2 agonist therapy in chronic obstructive pulmonary disease: a cluster analysis

... Cluster analysis of two replicate one-year studies of FF/VI versus vilanterol identified five clusters of patients with differing risks for occurrence of pneumonia or serious pneumonia. Using the cluster with the lowest ...

12

Clinical role of dual bronchodilation with an indacaterol–glycopyrronium combination in the management of COPD: its impact on patient-related outcomes and quality of life

Clinical role of dual bronchodilation with an indacaterol–glycopyrronium combination in the management of COPD: its impact on patient-related outcomes and quality of life

... the beta 2 -agonist, and thereby amplify the bronchodilation elicited by the same beta 2 -agonist through direct stimulation of beta 2 -adrenoceptors in smooth ...

10

Trend of cost and utilization of COPD medication in Korea

Trend of cost and utilization of COPD medication in Korea

... systemic beta ago- nists were most widely prescribed between 2008 and ...long-acting beta-2 agonist (LABA), long-acting muscarinic agonist, and inhaled corticosteroid plus LABA were ...

7

The effects of long-acting bronchodilators on total mortality in patients with stable chronic obstructive pulmonary disease

The effects of long-acting bronchodilators on total mortality in patients with stable chronic obstructive pulmonary disease

... The mechanism by which ICS/LABA combination reduces total mortality in COPD is uncertain. It is now well recognized that COPD is an inflammatory disorder, characterized by persistent lung and systemic inflamma- tion, ...

13

Functional imaging using computer methods to compare the effect of salbutamol and ipratropium bromide in patient-specific airway models of COPD

Functional imaging using computer methods to compare the effect of salbutamol and ipratropium bromide in patient-specific airway models of COPD

... Using functional imaging, we demonstrated that central but mainly distal airway dimensions (third to seventh bifurcation) increased significantly after an inhaled beta 2 -agonist (salbutamol) and ...

10

Do beta –2 Agonists reduce Admission rate in children with bronchiolitis?

Do beta –2 Agonists reduce Admission rate in children with bronchiolitis?

... of beta-2 agonist in children with bronchiolitis and they did not find any true benefits of beta-2 agonists and they did not encourage the routine use of beta-2 ...

20

Effect of sympathomimetics on gastrin secretion from antral G cells in culture

Effect of sympathomimetics on gastrin secretion from antral G cells in culture

... a beta- adrenergic ...of beta-adrenergic receptors on the G ...(a beta 2 agonist) significantly stimulated gastrin release above basal which could be blocked by the addition of ...

6

Validation of sensitive spectrophotometric method for determination of Salmeterol xinafoate and Fenoterol hydrobromide via o-Phenanthroline and iron complexation

Validation of sensitive spectrophotometric method for determination of Salmeterol xinafoate and Fenoterol hydrobromide via o-Phenanthroline and iron complexation

... A Simple, accurate and sensitive spectrophotometric method has been established and validated for the determination of two selective beta-2 agonist drugs namely; Salmeterol xinafoate and Fenoterol ...

6

Reactivation of latent HIV 1 in central memory CD4+T cells through TLR 1/2 stimulation

Reactivation of latent HIV 1 in central memory CD4+T cells through TLR 1/2 stimulation

... in 2 of the 7 patients compared with 5 of 7 for ...of 2 ART-suppressed patients, although, as is gen- erally seen with HDAC inhibitors, the frequency of induc- tion of HIV outgrowth was greater after cells ...

15

A qualitative evaluation of the implementation of guidelines and a support tool for asthma management in primary care

A qualitative evaluation of the implementation of guidelines and a support tool for asthma management in primary care

... Seven focus group sessions were held with key stake- holders in asthma management in the primary care setting and those targeted in the SABA guideline and AAP card im- plementation. Including a range of stakeholder ...

16

Effects of Dietary Beta-Adrenergic Agonist, Terbutaline, on Carcass Characteristics and Blood Attributes in Japanese Quails (Coturnix coturnix japonica)

Effects of Dietary Beta-Adrenergic Agonist, Terbutaline, on Carcass Characteristics and Blood Attributes in Japanese Quails (Coturnix coturnix japonica)

... 2007). Beta- adrenergic agonists have considerable effects on carcass characteristics (Mersmann, ...of beta agonists in improved feed utilization, increased leanness, increased dressing percentage, ...

9

Combination of roflumilast with a beta-2 adrenergic receptor agonist inhibits proinflammatory and profibrotic mediator release from human lung fibroblasts

Combination of roflumilast with a beta-2 adrenergic receptor agonist inhibits proinflammatory and profibrotic mediator release from human lung fibroblasts

... Fibroblasts can both respond to, and secrete proin- flammatory cytokines. The well characterized proinflam- matory cytokine, TNFa, in our model system induced secretion of CXCL10, CCL5 and GM-CSF. CXCL10 and CCL5 are ...

11

Beta Adrenergic Receptors of Polymorphonuclear Particulates in Bronchial Asthma

Beta Adrenergic Receptors of Polymorphonuclear Particulates in Bronchial Asthma

... In further studies we examined the interaction of the agonist (−)-isoproterenol with beta adrenergic receptors in 8 normal subjects and 10 asthmatics not receiving adrenergic medication. We tested the ...

10

Profile of mirabegron in the treatment of overactive bladder: place in therapy

Profile of mirabegron in the treatment of overactive bladder: place in therapy

... the Beta-3 Agonist Mirabegron (YM178) in Patients With Symptoms of Over- active Bladder (SCORPIO), Study to Test the Efficacy and Safety of the Beta-3 Agonist Mirabegron (YM178) in Patients ...

5

Role of alpha adrenoceptors in opossum internal anal sphincter

Role of alpha adrenoceptors in opossum internal anal sphincter

... alpha- 2 adrenoceptors exert important neuromodulatory influences on rectoanal inhibitory reflex, while alpha-1 adrenoceptors may exert modulatory effects on the resting IAS ...

7

Protective effects of a glucocorticoid on downregulation of pulmonary beta 2 adrenergic receptors in vivo

Protective effects of a glucocorticoid on downregulation of pulmonary beta 2 adrenergic receptors in vivo

... increased beta 1- and beta 2-receptor numbers by 70 and 69% above control, respectively, but did not change their mRNA ...days 2-8) decreased beta 1- and beta 2-receptor ...

9

The beta-3 adrenergic agonist (CL-316,243) restores the expression of down-regulated fatty acid oxidation genes in type 2 diabetic mice

The beta-3 adrenergic agonist (CL-316,243) restores the expression of down-regulated fatty acid oxidation genes in type 2 diabetic mice

... by 2–3 weeks of age, and hypergly- cemia by 5–6 weeks of age with decreased whole body glucose uptake, failure to suppress hepatic gluconeogen- esis in response to insulin and pancreatic beta cell ...

14

C Jun NH2 Terminal Kinase Contributes to Dexmedetomidine Induced Contraction in Isolated Rat Aortic Smooth Muscle

C Jun NH2 Terminal Kinase Contributes to Dexmedetomidine Induced Contraction in Isolated Rat Aortic Smooth Muscle

... lysed in PRO-PREP protein extract solution for total cell lysates, and the lysates were centrifuged at 100,000×g for 20 min at 4°C. Protein concentration was determined using the Bradford method. For preparation of ...

9

Show all 10000 documents...

Related subjects